Lyomark Pharma GmbH

About Lyomark Pharma GmbH

Lyomark is specialised in niche proprietary and generic products and orphan drugs for rare diseases, presented as sterile injectable, lyophilized formulations in pre-filled syringes, vials and ampoule's. Lyomark is active in the area of respiratory disease, oncology, metabolism etc.

  • DE
  • 2015
    On CPHI since
Company types
Distributor/Import Export
Licensee
Contact info

Products from Lyomark Pharma GmbH (3)

  • Alveofact® - Natural bovine lung surfactant

    Product Alveofact® - Natural bovine lung surfactant

    Alveofact is used in neonates. Preventive use in premature neonates with a high risk of respiratory distress syndrome (RDS).
    Active substance: Phospholipid fractionfrom bovine lung (surfactant)
  • Neofact® - Medical device for surfactant application

    Product Neofact® - Medical device for surfactant application

    Neofact is an innovative applicator for instillation of surfactant and is used for the management of respiratory distress syndrome (RDS) in preterm and term neonates:

    • Simple and practical handling • Application of surfactant without Magill forceps • Precise positioning in ...
  • Neofact - Clinical evaluation of an application aid for less-invasive surfactant administration (LISA)

    Product Neofact - Clinical evaluation of an application aid for less-invasive surfactant administration (LISA)

    Neofact, by Lyomark Pharma, is a medical device for neonates suffering from RDS. 
    This study shows that the LISA method (less invasive surfactant administration) via Neofact® appears feasible. 

    Neofact® makes surfactant application easy and is also suitable for all gesta...

Lyomark Pharma GmbH Resources (2)